Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label, Parallel-group, Randomized, Multicenter Study to Assess the Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids Versus Standard of Care

NCT03194646 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT03194646
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03194646 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label, Parallel-group, Randomized, Multicenter Study to Assess the Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids Versus Standard of Care
Lead sponsor
Bayer
Phase
Phase 3
Overall status
Terminated
Start date
June 30, 2017
Completion date
July 11, 2024
Enrollment
1,272 (actual)
Sites
219

Conditions

As the registry lists them; a condition with its own page is linked.

uterine fibroids